BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1691478)

  • 21. Encounters with Fos and Jun on the road to AP-1.
    Abate C; Curran T
    Semin Cancer Biol; 1990 Feb; 1(1):19-26. PubMed ID: 2133107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The carboxy terminus of the viral Jun oncoprotein is required for complex formation with the cellular Fos protein.
    Bos TJ; Rauscher FJ; Curran T; Vogt PK
    Oncogene; 1989 Feb; 4(2):123-6. PubMed ID: 2494630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA binding.
    Kouzarides T; Ziff E
    Nature; 1989 Aug; 340(6234):568-71. PubMed ID: 2505081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence and possible role of c-ras and nuclear (c-fos and c-jun) proto-oncogene products in preimplantation embryonic development in mice.
    Ahmad K; Naz RK
    Mol Reprod Dev; 1993 Nov; 36(3):297-306. PubMed ID: 8286110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
    Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
    Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1.
    Macgregor PF; Abate C; Curran T
    Oncogene; 1990 Apr; 5(4):451-8. PubMed ID: 2139203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins.
    Kerppola TK; Curran T
    Oncogene; 1994 Nov; 9(11):3149-58. PubMed ID: 7936637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes.
    Bannister AJ; Cook A; Kouzarides T
    Oncogene; 1991 Jul; 6(7):1243-50. PubMed ID: 1907361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered protein conformation on DNA binding by Fos and Jun.
    Patel L; Abate C; Curran T
    Nature; 1990 Oct; 347(6293):572-5. PubMed ID: 2120592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA-binding activity of Jun is increased through its interaction with Fos.
    Allegretto EA; Smeal T; Angel P; Spiegelman BM; Karin M
    J Cell Biochem; 1990 Apr; 42(4):193-206. PubMed ID: 2111328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
    Deng T; Karin M
    Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetic characterization of epitope-specific monoclonal antibodies against the myc family proteins.
    Ikegaki N; Kennett RH
    Oncogene; 1990 Mar; 5(3):397-403. PubMed ID: 1690381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements.
    Sassone-Corsi P; Ransone LJ; Verma IM
    Oncogene; 1990 Mar; 5(3):427-31. PubMed ID: 2107494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of PDGF-induced c-jun and c-fos expression by a tyrosine protein kinase inhibitor.
    Zwiller J; Sassone-Corsi P; Kakazu K; Boynton AL
    Oncogene; 1991 Feb; 6(2):219-21. PubMed ID: 1900355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Denervation of mouse skeletal muscle differentially affects the expression of the jun and fos proto-oncogenes.
    Bessereau JL; Fontaine B; Changeux JP
    New Biol; 1990 Apr; 2(4):375-83. PubMed ID: 2126956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. fos-jun conspiracy: implications for the cell.
    Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
    Ciba Found Symp; 1990; 150():128-37; discussion 137-46. PubMed ID: 2115424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Domain swapping reveals the modular nature of Fos, Jun, and CREB proteins.
    Ransone LJ; Wamsley P; Morley KL; Verma IM
    Mol Cell Biol; 1990 Sep; 10(9):4565-73. PubMed ID: 2143806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fos-Jun interaction: mutational analysis of the leucine zipper domain of both proteins.
    Ransone LJ; Visvader J; Sassone-Corsi P; Verma IM
    Genes Dev; 1989 Jun; 3(6):770-81. PubMed ID: 2501150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.